EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis

Alberto Aimo, Yu Fu Ferrari Chen iD, Michela Chianca iD, Francesco Mori iD, Angela Pucci iD, Vincenzo Castiglione, Veronica Musetti iD, Laura Caponi, Iacopo Fabiani, Giuseppe Vergaro, Maria Franzini, Michele Emdin und 1 weitere

International Journal of Molecular Sciences · 29.09.2025 · 26 (19) · 9511

DOI: 10.3390/ijms26199511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.09.2025. Verfasst von Alberto Aimo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Interdisciplinary Center, Scuola Superiore Sant'Anna, 56127 Pisa, Italy. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Biomarkers, Immunoglobulin Light Chains. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid light-chain (AL) amyloidosis is the most prevalent type of diagnosed systemic amyloidosis in Western countries, characterized by the deposition of misfolded immunoglobulin light chains (LCs) in various organs, most commonly the heart and kidneys. Circulating free LC (FLC) measurement, which can be performed by mass spectrometry or antibody-based techniques, is a crucial tool for AL amyloidosis diagnosis, risk assessment, and management. Additionally, diagnosing AL amyloidosis requires accurate detection of LC deposits in tissues. In addition to immunohistochemical techniques, mass spectrometry-based methods are now available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Light-chain AmyloidosisBiomarkersImmunoglobulin Light ChainsHumansMass Spectrometry

Stichwörter der Autor:innen

AL amyloidosisamyloid fibrilsfree light-chainsheart failureimmunoglobulinplasma cell disorder

Substanzen

BiomarkersImmunoglobulin Light Chains

Autor:innen und Institutionen

  • Health Sciences Interdisciplinary Center, Scuola Superiore Sant'Anna, 56127 Pisa, Italy.
  • Fondazione Toscana Gabriele Monasterio, 56124 Pisa, Italy.
  • University Hospital of Pisa, 56100 Pisa, Italy.
  • Cardioncology Unit, Cardioncology and Second Opinion Division, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, 20141 Milan, Italy.

ORCID-Profile: Yu Fu Ferrari Chen, Michela Chianca, Francesco Mori, Angela Pucci, Veronica Musetti, Daniela Cardinale

Zitieren

APA

Aimo, A., Ferrari Chen, Y. F., Chianca, M., Mori, F., Pucci, A., Castiglione, V., Musetti, V., Caponi, L., Fabiani, I., Vergaro, G., Franzini, M., Emdin, M., & Cardinale, D. (2025). Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis. International Journal of Molecular Sciences, 26(19), 9511. https://doi.org/10.3390/ijms26199511

Vancouver

Aimo A, Ferrari Chen YF, Chianca M, Mori F, Pucci A, Castiglione V, et al. Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis. International Journal of Molecular Sciences. 2025;26(19):9511. doi:10.3390/ijms26199511

BibTeX
@article{Aimo2025,
  author = {Aimo, Alberto and Ferrari Chen, Yu Fu and Chianca, Michela and Mori, Francesco and Pucci, Angela and Castiglione, Vincenzo and Musetti, Veronica and Caponi, Laura and Fabiani, Iacopo and Vergaro, Giuseppe and Franzini, Maria and Emdin, Michele and Cardinale, Daniela},
  title = {Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9511},
  doi = {10.3390/ijms26199511}
}
Kostenlos starten →